2500 — Venus MedTech HangZhou Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | -382 | -186 | -378 | -1,156 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 128 | 23.9 | -4.13 | 439 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -78.5 | -113 | -127 | -125 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -303 | -237 | -457 | -729 | — |
Capital Expenditures | -24.5 | -124 | -145 | -179 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -6.44 | -174 | -508 | -893 | — |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -31 | -298 | -653 | -1,072 | — |
Financing Cash Flow Items | -133 | -251 | 45.3 | -66.5 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2,577 | 928 | 1,391 | 635 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,248 | 295 | 247 | -1,076 | — |